British Journal of Anaesthesia, 2002, Vol. 89, No. 2 306-324
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia
Chemical and biological weapons. Implications for anaesthesia and intensive care
Department of Anaesthesia, Guy’s and St Thomas’ Hospital Trust, St Thomas’ Street, London SE1 9RT, UK
This article is accompanied by Editorial I.
Abstract
In the wake of recent atrocities there has been renewed apprehension regarding the possibility of chemical and biological weapon (CBW) deployment by terrorists. Despite various international agreements that proscribe their use, certain states continue to develop chemical and biological weapons of mass destruction. Of greater concern, recent historical examples support the prospect that state-independent organizations have the capability to produce such weapons. Indeed, the deliberate deployment of anthrax has claimed several lives in the USA since September 11, 2001. In the event of a significant CBW attack, medical services would be stretched. However, victim survival may be improved by the prompt, coordinated response of military and civil authorities, in conjunction with appropriate medical care. In comparison with most other specialties, anaesthetists have the professional academic background in physiology and pharmacology to be able to understand the nature of the injuries caused by CBWs. Anaesthetists, therefore, play a vital role both in the initial resuscitation of casualties and in their continued treatment in an intensive care setting. This article assesses the current risk of CBW deployment by terrorists, considers factors which would affect the severity of an attack, and discusses the pathophysiology of those CBWs most likely to be used. The specific roles of the anaesthetist and intensivist in treatment are highlighted.
Br J Anaesth 2002; 89: 306–24
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. F. Dembek, L. A. Smith, and J. M. Rusnak Botulism: Cause, Effects, Diagnosis, Clinical and Laboratory Identification, and Treatment Modalities Disaster Med Public Health Preparedness, November 1, 2007; 1(2): 122 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Geoghegan and J. L Tong Chemical warfare agents CEACCP, December 1, 2006; 6(6): 230 - 234. [Full Text] [PDF]
|
|
|
|
 |
|
 S M White and T M Palfreman Nicotinic antagonists and nerve gas poisoning J R Soc Med, July 1, 2005; 98(7): 336 - 336. [Full Text] [PDF]
|
|
|
|
|
|
V P. Nair and J. M Hunter Anticholinesterases and anticholinergic drugs CEACCP, October 1, 2004; 4(5): 164 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Sigurdsson Anesthesiologists Should Be Familiar with the Management of Victims of Terrorist Attacks Anesth. Analg., June 1, 2004; 98(6): 1743 - 1745. [Full Text] [PDF]
|
|
|
|
 |
|
 R M Maynard and T D Tetley Bioterrorism: the lung under attack Thorax, March 1, 2004; 59(3): 188 - 189. [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Lawes Hidden hazards and dangers associated with the use of HME/filters in breathing circuits. Their effect on toxic metabolite production, pulse oximetry and airway resistance Br. J. Anaesth., August 1, 2003; 91(2): 249 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Berkenstadt, A. Ziv, D. Barsuk, I. Levine, A. Cohen, and A. Vardi The Use of Advanced Simulation in the Training of Anesthesiologists to Treat Chemical Warfare Casualties Anesth. Analg., June 1, 2003; 96(6): 1739 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Shirley and D. J. Baker Treatment of biological and chemical casualties in the UK Br. J. Anaesth., January 1, 2003; 90(1): 106 - 107. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Baker Editorial I: Management of casualties from terrorist chemical and biological attack: a key role for the anaesthetist Br. J. Anaesth., August 1, 2002; 89(2): 211 - 214. [Full Text] [PDF]
|
|